Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé
P
P
Department of Surgery, Virchow Clinic, Berlin, Germany.
Bechstein
W O
WO
Blumhardt
G
G
Lange
D
D
Schattenfroh
N
N
Neuhaus
P
P
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011446:Prospective Studies; D012189:Retrospective Studies; D013256:Steroids / Q000009:adverse effects*; D016559:Tacrolimus / Q000627:therapeutic use*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D011239:Prednisolone; D001379:Azathioprine; D016559:Tacrolimus